» Articles » PMID: 7843101

Influence of the Common Human Delta-aminolevulinate Dehydratase Polymorphism on Lead Body Burden

Overview
Date 1994 Sep 1
PMID 7843101
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

delta-Aminolevulinate dehydratase (ALAD) is the second enzyme in the heme biosynthesis pathway. ALAD is a zinc metalloenzyme, and its inhibition by lead substitution for zinc is one of the most sensitive indicators of blood-lead accumulation, a measure of recent lead exposure. Stoichiometry calculations indicate that a significant portion of blood lead is stored in ALAD. Human ALAD exhibits a charge polymorphism, with about 20% of Caucasians expressing the rarer ALAD2 allele. Human ALAD1 and ALAD2 cDNAs and the 16-kb ALAD gene have been cloned and sequenced. A simple polymerase chain reaction test has been established and validated for determining ALAD genotypes. Two population studies have indicated that lead-exposed individuals with the ALAD2 allele have blood-lead levels about 10 micrograms/dl greater than similarly exposed individuals carrying only the ALAD1 allele. Ongoing work is directed toward determining the biochemistry underlying the allele-specific accumulation of blood lead, and toward determining the contribution of human ALAD genotype to lead accumulation in other tissues in transgenic mouse models and to final lead deposition in bone in both mouse and man.

Citing Articles

Use of Generalized Additive Model to Detect the Threshold of δ-Aminolevulinic Acid Dehydratase Activity Reduced by Lead Exposure.

Huang C, Yang C, Liu T, Dai C, Wang C, Chuang H Int J Environ Res Public Health. 2020; 17(16).

PMID: 32784669 PMC: 7460038. DOI: 10.3390/ijerph17165712.


Genetic Risk Factors for Essential Tremor: A Review.

Siokas V, Aloizou A, Tsouris Z, Liampas I, Aslanidou P, Dastamani M Tremor Other Hyperkinet Mov (N Y). 2020; 10:4.

PMID: 32775018 PMC: 7394223. DOI: 10.5334/tohm.67.


Lead: Tiny but Mighty Poison.

Sachdeva C, Thakur K, Sharma A, Sharma K Indian J Clin Biochem. 2018; 33(2):132-146.

PMID: 29651203 PMC: 5891462. DOI: 10.1007/s12291-017-0680-3.


δ-Aminolevulinate Dehydratase Activity is Stimulated in a MPTP Mouse Model of Parkinson's Disease: Correlation with Myeloperoxidase Activity.

Sampaio T, Marcondes Sari M, Pesarico A, Nogueira C Cell Mol Neurobiol. 2016; 37(5):911-917.

PMID: 27650074 PMC: 11482109. DOI: 10.1007/s10571-016-0428-2.


Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study.

Ding N, Wang X, Weisskopf M, Sparrow D, Schwartz J, Hu H PLoS One. 2016; 11(9):e0161472.

PMID: 27584680 PMC: 5008632. DOI: 10.1371/journal.pone.0161472.


References
1.
Muller W, Snyder S . delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. Ann Neurol. 1977; 2(4):340-2. DOI: 10.1002/ana.410020415. View

2.
Astrin K, Bishop D, Wetmur J, Kaul B, DAVIDOW B, Desnick R . delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann N Y Acad Sci. 1987; 514:23-9. DOI: 10.1111/j.1749-6632.1987.tb48757.x. View

3.
Anderson P, Desnick R . Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes. J Biol Chem. 1979; 254(15):6924-30. View

4.
Brennan M, Cantrill R . Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors. Nature. 1979; 280(5722):514-5. DOI: 10.1038/280514a0. View

5.
Doss M, von Tiepermann R, Schneider J, Schmid H . New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Klin Wochenschr. 1979; 57(20):1123-7. DOI: 10.1007/BF01481493. View